Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs

OBJECTIVE: To examine the association between initiating first-line (1L) monotherapy with eslicarbazepine acetate (ESL) vs a generic antiseizure drug (ASD) and healthcare resource utilization (HCRU) and charges in adults with treated focal seizures (FS). METHODS: This was a retrospective analysis of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinicoecon Outcomes Res
Hlavní autoři: Mehta, Darshan, Davis, Matthew, Epstein, Andrew J, Wensel, Brian, Grinnell, Todd, Williams, G Rhys
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064618/
https://ncbi.nlm.nih.gov/pubmed/33907433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S303079
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky